News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Yan Leyfman: New Data – CAR-T Outcomes in Extranodal DLBCL 
Yan Leyfman
Jun 25, 2025, 03:19

Yan Leyfman: New Data – CAR-T Outcomes in Extranodal DLBCL 

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:

“New Data: CAR-T Outcomes in Extranodal DLBCL 
Extranodal (EN) DLBCL has long been linked to worse survival, but how do these patients fare after CAR-T therapy? A new multi-center study sheds light:
  •  218 patients with EN DLBCL treated with CAR-T in the relapsed/refractory setting
  •  Most common EN sites: Skin/soft tissue (25%), Bone (22%), Lung (17%)
  •  Overall Response Rate (ORR): 62% | Complete Response Rate (CRR): 40%
  •  Median PFS: 4 months | Median OS: 25.7 months
  •  High-risk factors for worse OS: ≥3 prior therapy lines, bulky disease, liver/pancreas involvement
CRS and ICANS were consistent with known CAR-T safety profiles. Future studies are needed to optimize CAR-T outcomes in high-risk EN DLBCL subgroups, especially those with hepatobiliary involvement.”

Title: Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma—Results from a multicenter cohort study

Authors: Frederique St-Pierre, Subodh Bhatta, Peter G. Doukas, Madeline Jenkin, Kaitlin Annunzio, Alexandra E. Rojek, Alyssa Gibson, Yun Kyoung Tiger, Brittany McCall, Khaled Alhamad, Alec Hansen, Juan P. Alderuccio, Olutobi Adewale, Keem Patel, Asaad Trabolsi, Izidore S. Lossos, Lindsey Fitzgerald, Thomas A. Ollila, Matthew J. Matasar, Justin Kline, Reem Karmali, Narendranath Epperla

Read the Full Article.

Yan Leyfman

More posts featuring Yan Leyfman on OncoDaily.

Alec Hansen Alexandra E. Rojek Alyssa Gibson Asaad Trabolsi Brittany McCall cancer Frederique St-Pierre Izidore S. Lossos Juan P. Alderuccio Justin Kline Kaitlin Annunzio Keem Patel Khaled Alhamad Lindsey Fitzgerald Madeline Jenkin Matthew J. Matasar Narendranath Epperla Olutobi Adewale OncoDaily Oncology Peter G. Doukas Reem Karmali Subodh Bhatta Thomas A. Ollila Yan Leyfman Yun Kyoung Tiger
Special Coverage
Insight
Jun 27, 2025, 03:03
Sibylle Loibl: Final survival Results from the PENELOPE-B trial published in Annals of Oncology
Blog
Jun 26, 2025, 19:30
Getting Ready to Make the Most of Upcoming Events - EORTC
Blog
Jun 26, 2025, 19:22
Tobacco Taxation Gains Momentum in Kenya and Uganda Through Civil Society Mobilisation - UICC
Blog
Jun 26, 2025, 18:56
Late Breaking Abstract Submission Is Open - European Association of Neuro-Oncology
Blog
Jun 26, 2025, 18:44
Winan van Houdt: Pleased to Be Invited to the First Colombian Conference of Surgical Oncology
Positive
Jun 26, 2025, 18:34
Improving Life After Cancer for Survivors of Childhood and Adolescent Cancer - SIOP Europe
Blog
Jun 26, 2025, 18:18
Vote for Xploro to Win People’s Choice Award at CancerX Accelerator 2025 - World Child Cancer USA
Career
Jun 26, 2025, 18:06
Penn State Health Children's Hospital Is Seeking a Director for the Solid Tumor Program
Insight
Jun 26, 2025, 17:54
E. Shyam P. Reddy: Obesity Drugs Might also Tackle Migraine
Opinion
Jun 26, 2025, 17:47
MASCC 2025 Highlights: Global Crisis of Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:46
MASCC 2025 Highlights BVGH’s Global Solutions to Financial Toxicity in Cancer Care
Oncolibrary
Jun 26, 2025, 17:45
MASCC 2025 Highlights: Addressing Financial Toxicity in Cancer Supportive Care